AMBROSETTI, Achille
 Distribuzione geografica
Continente #
EU - Europa 9.008
NA - Nord America 8.815
AS - Asia 5.243
SA - Sud America 735
AF - Africa 93
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 23.938
Nazione #
US - Stati Uniti d'America 8.696
GB - Regno Unito 2.599
RU - Federazione Russa 2.534
CN - Cina 2.018
SG - Singapore 1.996
DE - Germania 755
IT - Italia 727
BR - Brasile 623
SE - Svezia 618
FR - Francia 517
HK - Hong Kong 444
FI - Finlandia 423
IE - Irlanda 416
VN - Vietnam 281
UA - Ucraina 161
KR - Corea 102
IN - India 77
CA - Canada 62
TR - Turchia 60
AR - Argentina 51
ID - Indonesia 47
BE - Belgio 38
JP - Giappone 36
PL - Polonia 35
AU - Australia 32
BD - Bangladesh 31
IR - Iran 31
MX - Messico 29
NL - Olanda 29
ES - Italia 27
ZA - Sudafrica 27
CZ - Repubblica Ceca 21
AT - Austria 19
IQ - Iraq 18
EC - Ecuador 16
RO - Romania 14
CO - Colombia 13
NP - Nepal 11
AE - Emirati Arabi Uniti 10
GR - Grecia 10
MA - Marocco 10
UZ - Uzbekistan 10
EU - Europa 9
SA - Arabia Saudita 9
AZ - Azerbaigian 8
DZ - Algeria 8
LT - Lituania 8
PE - Perù 8
TH - Thailandia 8
TN - Tunisia 8
CH - Svizzera 7
EG - Egitto 7
ET - Etiopia 7
GH - Ghana 7
LV - Lettonia 7
PK - Pakistan 7
PY - Paraguay 7
VE - Venezuela 7
CL - Cile 6
DK - Danimarca 5
KZ - Kazakistan 5
NO - Norvegia 5
PA - Panama 5
AL - Albania 4
BG - Bulgaria 4
CG - Congo 4
DO - Repubblica Dominicana 4
LB - Libano 4
LK - Sri Lanka 4
NI - Nicaragua 4
PT - Portogallo 4
CM - Camerun 3
CR - Costa Rica 3
EE - Estonia 3
HU - Ungheria 3
JM - Giamaica 3
KE - Kenya 3
LU - Lussemburgo 3
PH - Filippine 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GE - Georgia 2
KG - Kirghizistan 2
MD - Moldavia 2
MY - Malesia 2
OM - Oman 2
PS - Palestinian Territory 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AQ - Antartide 1
BH - Bahrain 1
BJ - Benin 1
BW - Botswana 1
Totale 23.916
Città #
Southend 2.234
Jacksonville 1.283
Chandler 1.029
Singapore 842
Woodbridge 823
Dallas 781
Moscow 766
Ashburn 572
Ann Arbor 540
Hong Kong 440
Dublin 415
Houston 362
Beijing 290
Wilmington 215
Jinan 193
Los Angeles 192
Lawrence 179
Princeton 179
Buffalo 170
Nanjing 165
Shenyang 156
New York 141
Hebei 102
The Dalles 101
Boardman 100
Helsinki 82
Ho Chi Minh City 81
Columbus 74
Sindelfingen 70
Tianjin 70
Zhengzhou 67
Munich 66
São Paulo 65
Verona 63
Milan 62
Hangzhou 58
Changsha 57
Seattle 57
Haikou 56
Taizhou 55
Nanchang 54
Hanoi 50
Jiaxing 49
Guangzhou 46
Philadelphia 46
Dong Ket 45
Ningbo 45
Santa Clara 42
Falls Church 41
Council Bluffs 39
Fairfield 39
Rome 39
Turku 37
Brussels 35
Cambridge 35
Jakarta 34
Redondo Beach 34
Taiyuan 31
Norwalk 30
Lanzhou 28
Seoul 28
Tokyo 27
Warsaw 26
Fuzhou 25
Dearborn 24
Lancaster 24
Montreal 24
Frankfurt am Main 23
London 23
Brooklyn 22
Redwood City 22
Bologna 21
Redmond 21
Stockholm 20
Toronto 20
Rio de Janeiro 19
Belo Horizonte 18
San Francisco 18
Washington 18
Atlanta 17
Auburn Hills 16
Phoenix 16
Provo 16
Brno 15
Düsseldorf 15
Chennai 14
Johannesburg 14
Boston 13
Denver 13
Falkenstein 13
Perth 13
Brasília 12
Vienna 12
Chicago 11
Haiphong 11
Nuremberg 11
Orem 11
Biên Hòa 10
Leawood 10
Manchester 10
Totale 14.748
Nome #
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 411
A simplified immunological approach to the diagnosis of chronic lymphocytic leukaemia and other lymphoproliferative disorders 258
Linfomi del tessuto linfatico associato alle mucose (MALT) delle ghiandole salivari. Descrizione di un caso in un paziente con infezione da virus C dell'epatite e revisione della letteratura 230
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 218
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 217
Acute leukemia and pregnancy. Case report 210
Analisi del riarrangiamento bcr-abl in alcuni pazienti affetti da leucemia mieloide cronica 210
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 203
Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia 203
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 202
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia 201
An assessment of chimeric transcript detection in CML patients after bone marrow transplantation 200
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 194
Blood smear, a key diagnostic tool in hematology: Lessons from two cases of acute hemolysis in previously undiagnosed g6pd deficiency 193
BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC. 192
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma. 191
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 189
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies 188
[The use of betamethasone in polychemotherapy of lymphoproliferative diseases] 185
Anemie iporigenerative ipercromiche e macrocitiche 185
[Liver and spleen involvement in Hodgkin's disease: critical evaluation of diagnostic procedures (author's transl)] 184
[Clinical and pathological staging of 85 patients with Hodgkin's disease: a clinical contribution (author's transl)] 184
The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia 182
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 180
Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience 180
An unusual case of acute leukaemia 178
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 177
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 176
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML. 176
Predictive factors of stable deep molecular response in chronic myeloid leukemia patients treated with imatinib standard dose: a study from the Gruppo Triveneto LMC. 175
Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN) 173
Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML 170
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 170
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 169
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 168
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 168
Leucemie 168
B cells in chronic lymphocytic leukaemia. Comparative analysis of blood and bone marrow 167
Prognostic factors in acute non-lymphocytic leukemia with respect to treatment response 167
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations 167
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 166
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 166
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 164
2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma [see comments] 163
Primary extranodal lymphomas of Waldeyer's ring, stage IE and IIE: Long-term survival after chemotherapy combined with radiotherapy 160
Chirurgia e chemioterapia nel trattamento dei linfomi gastrici primitivi: revisione casistica 159
CT imaging of primary pancreatic lymphoma: experience from three referral centres for pancreatic diseases 159
Soluble interleukin-2 receptor in the serum of patients with Hodgkin's Disease: A new biological marker of disease activity 158
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi 158
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment naive chronic lymphocytic leukemia 155
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 154
Bone marrow transplantation monitoring by DNA analysis 154
Folic acid binding protein in chronic granulocytic leukaemia: the effect of methotrexate 154
Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C? 153
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 151
CT IMAGING OF PRIMARY PANCREATIC LYMPHOMA 150
the International Extranodal Lymphoma Study group (IELSG). Intravascular lymphoma: clinical presentation, natural history, management, and prognostic factors in a series of 38 cases, with special emphasis on the “cutaneous variant”. 148
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia 148
Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies 147
Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction 145
Unicentric Castleman's lymphadenopathy presenting with Behcet's syndrome: a case report 145
Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases 145
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. 145
Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response 145
Use of prothrombin complex concentrate for prophylaxis of bleeding in acquired factor X deficiency associated with light-chain amyloidosis 145
Valutazione del significato della cupremia come indice di attività e come segno precoce di ricaduta nel cancro della mammella e nel morbo di Hodgkin (studio su 270 Casi). 144
Comparison of dasatinib and nilotinib as second-line therapy after imatinib failure in chronic phase chronic myeloid leukemia patients. 144
OFATUMUMAB AND LENALIDOMIDE PREFERENTIALLY INHIBIT B-CELL RECEPTOR SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS WITH MUTATED IGHV 144
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma 144
Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lymphoma 142
Regulation of the proliferative potential of cord blood long term culture initiating cells (LTC-IC) by different stromal cell lines: implications for LTC-IC measurement 142
Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy 142
Mycobacterial infections preceding hairy-cell leukemia diagnosis. Description of two cases 141
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas. 141
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 141
Molecular “warning” CML patients: a retrospective study of Gruppo Triveneto LMC. 141
Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia 140
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma 140
Terminal transferase expression in relapsed acute myeloid leukaemia 139
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 138
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis 138
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 137
Clinical value of PCR in diagnosis and follow-up of leukaemia and lymphoma: report of the Third Workshop of the Molecular Biology/BMT Study Group 137
Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease 135
Distribution and heterogeneity of cells detected by HNK-1 monoclonal antibody in blood and tissues in normal, reactive and neoplastic conditions 134
Pilot study of survival of patients with chronic myeloid leukemia after determination of intracellular folate binding protein (FABP) 134
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". 134
Serum levels of soluble CD30 improve international prognostic score in predicting the outcome of advanced Hodgkin's lymphoma 133
The combination of Serum Thymidine Kinase, Beta-2-Microglobulin and soluble CD23 at diagnosis is predictive for progression in B-cell Chronic Lymphocytic Leukemia, independently from ZAP-70 expression 133
BCR breakpoint subregions and blast crisis lineage in CML patients 132
Real-life comparison of dasatinib and nilotinib as second-line therapy after imatinib failure for chronic phase CML 132
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival 131
Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice 128
Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia 126
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor. 126
Remission of severe antiphospholipid syndrome associated with non Hodgkin's B-cell lymphoma after combined treatment with Rituximab and chemotherapy 126
Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-cell chronic lymphocytic leukemia. 125
Immunohistologic study of bone marrow involvement in B-chronic lymphocytic leukemia 124
Soluble interleukin-2 receptor in hairy cell leukemia: A reliable marker of disease 124
Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-a. 122
Totale 16.330
Categoria #
all - tutte 75.352
article - articoli 60.922
book - libri 0
conference - conferenze 11.886
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.544
Totale 150.704


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.146 0 0 0 0 163 247 21 138 147 25 265 140
2021/20221.494 144 426 15 113 86 45 33 92 59 39 134 308
2022/20232.990 229 282 292 549 311 705 47 155 314 25 62 19
2023/20241.441 69 143 131 176 157 202 59 104 17 73 196 114
2024/20253.758 265 228 119 623 242 146 186 181 579 194 294 701
2025/20265.573 755 604 862 1.493 1.859 0 0 0 0 0 0 0
Totale 24.119